SCUBE2 and neoplasm: Parris et al. (2014) predicted the association of SCUBE2 with CBX2 and STK32B in the appearance of clinical–pathological characteristics, including increased tumor size, metastatic spread to cervical lymph nodes, and peritumoral inflammatory infiltration.